Correction: Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury

• by Junzhuo Wang, Ziwei Chen, Qing Dai, Jinxuan Zhao, Zilun Wei, Jiaxin Hu, Xuan Sun, Jun Xie, Biao Xu

• April 9, 2026

Investigating the function of ATP-sensitive potassium channels in the modulation of coronary metabolic vasodilation during physical activity

• by Salman I. Essajee, Cooper M. Warne, Johnathan D. Tune, Gregory M. Dick

• April 20, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

• by Kathryn Wighton

• May 18, 2026

• 2 min